MALAISE is the #4 most commonly reported adverse reaction for OCTREOTIDE ACETATE, manufactured by Novartis Pharmaceuticals Corporation. There are 2,989 FDA adverse event reports linking OCTREOTIDE ACETATE to MALAISE. This represents approximately 2.6% of all 115,420 adverse event reports for this drug.
OCTREOTIDE ACETATE has an overall safety score of 85 out of 100. Patients taking OCTREOTIDE ACETATE who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
MALAISE2,989 of 115,420 reports
MALAISE is a less commonly reported adverse event for OCTREOTIDE ACETATE, but still significant enough to appear in the safety profile.
Other Side Effects of OCTREOTIDE ACETATE
In addition to malaise, the following adverse reactions have been reported for OCTREOTIDE ACETATE:
MALAISE has been reported as an adverse event in 2,989 FDA reports for OCTREOTIDE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is MALAISE with OCTREOTIDE ACETATE?
MALAISE accounts for approximately 2.6% of all adverse event reports for OCTREOTIDE ACETATE, making it a notable side effect.
What should I do if I experience MALAISE while taking OCTREOTIDE ACETATE?
If you experience malaise while taking OCTREOTIDE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.